Answers are grounded in this paper and cite their sources.
Critical review highlights the need for improved understanding of rhabdomyolysis and AKI management.
Rhabdomyolysis, a clinical syndrome caused by damage to skeletal muscle and release of its breakdown products into the circulation, can be followed by acute kidney injury (AKI) as a severe complication. The belief that the AKI is triggered by myoglobin as the toxin responsible appears to be oversimplified. Better knowledge of the pathophysiology of rhabdomyolysis and following AKI could widen treatment options, leading to preservation of the kidney: the decision to initiate renal replacement therapy in clinical practice should not be made on the basis of the myoglobin or creatine phosphokinase serum concentrations.
No takes yet. Share an insight, caveat, or question.
Petejová et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: